Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
07 2020
Historique:
received: 31 12 2019
accepted: 26 03 2020
pubmed: 20 4 2020
medline: 16 6 2021
entrez: 20 4 2020
Statut: ppublish

Résumé

Glutaric aciduria type I (GA1; OMIM #231670) is an autosomal recessively inherited and treatable disorder characterized by the accumulation and irregular excretion of glutaric acid due to a defect in the glutaryl-CoA dehydrogenase enzyme involved in the catabolic pathways of L-lysine, L-hydroxylysine, and L-tryptophan. Glutaryl-CoA dehydrogenase is encoded by the GCDH gene (OMIM #608801), and several mutations in this gene are known to result in GA1. GA1 usually presents in the first 18-36 months of life with mild or severe acute encephalopathy, movement disorders, and striatal degeneration. Few cases of adult-onset GA1 have been described so far in the literature, often with non-specific and sometimes longstanding neurological symptoms. Since a preventive metabolic treatment is available, neurologists must be aware of this rare but likely underdiagnosed presentation, especially when typical neuroimaging features are identified. Here, we describe 35-year-old presenting with headache and subjective memory problems. There was no history of dystonic movement disorders. Neurological examination and neurocognitive tests were normal. Brain MRI scan revealed white matter abnormalities associated with subependymal nodules and mild frontotemporal hypoplasia suggestive of glutaric aciduria type 1 (GA1). Genetic testing confirmed the presence of homozygous c.1204C > T (p.R402W) variant in the GCDH gene, inherited from heterozygous parents.

Identifiants

pubmed: 32306145
doi: 10.1007/s10048-020-00610-9
pii: 10.1007/s10048-020-00610-9
doi:

Substances chimiques

Glutarates 0
Glutaryl-CoA Dehydrogenase EC 1.3.8.6
glutaric acid H849F7N00B

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-186

Auteurs

Pınar Gelener (P)

Department of Neurology, University of Kyrenia Faculty of Medicine, Kyrenia, Cyprus. drpinargelener@gmail.com.
Department of Neurology, Near East University Faculty of Medicine, Nicosia, Cyprus. drpinargelener@gmail.com.

Mariasavina Severino (M)

Department of Neuroradiology, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Sevda Diker (S)

Department of Neurology, Near East University Faculty of Medicine, Nicosia, Cyprus.

Kerem Teralı (K)

Department of Medical Biochemistry, Faculty of Medicine, Near East University, Nicosia, Cyprus.

Gulten Tuncel (G)

Department of Medical Biology, Faculty of Medicine, Near East University, Nicosia, Cyprus.
DESAM Institute, Near East University, Nicosia, Cyprus.

Hatice Tuzlalı (H)

Department of Neuroradiology, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Elena Manara (E)

MAGI Euregio, Bolzano, Italy.

Stefano Paolacci (S)

MAGI Euregio, Bolzano, Italy.

Matteo Bertelli (M)

MAGI's LAB S.r.l., Rovereto, Italy.

Mahmut Cerkez Ergoren (MC)

Department of Medical Biology, Faculty of Medicine, Near East University, Nicosia, Cyprus.
DESAM Institute, Near East University, Nicosia, Cyprus.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH